Tag Archives: CT-388

Roche to Acquire Carmot Therapeutics for USD 2.7 Billion, Expanding Its Portfolio in Obesity Treatment

(IN BRIEF) Roche, a leading pharmaceutical company, has announced its definitive merger agreement to acquire Carmot Therapeutics, a privately owned US-based company specializing in obesity treatment and related metabolic diseases. The acquisition includes Carmot’s portfolio of clinical stage subcutaneous and … Read the full press release